Polyphenon E regulatory update

FDA granted Orphan Drug designation for Polyphenon E from Polyphenon Pharma, a unit of Mitsui, to treat chronic lymphocytic leukemia (CLL). An oral formulation of the polyphenolic catechins, which ar...